Ian Orest Ihnatowycz

All filings by Ian Orest Ihnatowycz on record concern Acerus Pharmaceuticals Corporation. Between 29 March 2019 and 26 November 2020, the trades on record add up to 3 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 27 November 2020 with a transaction (€8.2M) in Acerus Pharmaceuticals Corporation. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.